Simultaneous Determination of Rupatadine and Its Metabolite Desloratadine in Human Plasma by a Sensitive LC–MS/MS Method: Application to the Pharmacokinetic Study in Healthy Chinese Volunteers

Jun Wen,Zhanying Hong,Yiwen Wu,Hua Wei,Guorong Fan,Yutian Wu

DOI: https://doi.org/10.1016/j.jpba.2008.10.014

IF: 3.571

2009-01-01

Journal of Pharmaceutical and Biomedical Analysis

Abstract:A sensitive liquid chromatography/tandem mass spectrometry (LC–MS/MS) method was developed for simultaneous determination of rupatadine and its metabolite desloratadine in human plasma. After the addition of diphenhydramine, the internal standard (IS), plasma samples were extracted with a mixture of methyl tert-butyl ether and n-hexane (1:1, v/v). The analysis was performed on a Ultimate™ AQ-C18 (4.6mm×100mm, 5μm) column using a mobile phase consisting of a 80/20 mixture of methanol/water containing 0.0005% formic acid pumped at 0.3mlmin−1. The analytes and the IS were detected in positive ionization mode and monitoring their precursor→product ion combinations of m/z 416→309, 311→259, and 256→167, respectively, in multiple reaction monitoring mode. The linear ranges of the assay were 0.1–50 and 0.1–20ngml−1 for rupatadine and desloratadine, respectively. The lower limits of reliable quantification for both rupatadine and desloratadine were 0.1ngml−1, which offered high sensitivity and selectivity. The within- and between-run precision was less than 7.2%. The accuracy ranged from −9.2% to +6.4% and −7.2% to +7.2% for rupatadine and desloratadine in quality control samples at three levels, respectively. The method has been successfully applied to a pharmacokinetic study of rupatadine and its major metabolite after oral administration of 10, 20 and 40mg rupatadine tablets to healthy Chinese volunteers.